FIRST TREATMENT APPROVED FOR PEOPLE WITH SPECIFIC TYPE OF ADVANCED BLADDER CANCER IN MORE THAN 30 YEARS



New bladder cancer treatment works with body's immune system in the fight against cancer 



Bladder cancer is the fifth most common cancer in the United States and, until recently, those with the advanced form of the disease might have received the same type of treatment as they would have in the 1980s. The FDA approves TECENTRIQ™ first new treatment in more than 30 years for specific bladder cancer.
 Dr. Arjun Balar, medical oncologist at NYU Langone and cancer patient Kevin Williamson discuss this new treatment. Article/Video

Comments

Post a Comment

Popular posts from this blog

Safest States During the COVID-19 Pandemic – Updated

Image
  U.S. adults who report being vaccinated for COVID-19 or intending to do so as soon as possible continues to rise (currently 61%) and the share taking a “wait and see” approach continues to shrink (now 17%). However, 13% say they will “definitely not” get the vaccine and this percentage has basically remained the same since December, according to the latest KFF COVID-19 Vaccine Monitor . According to the CDC as of March 30 New Mexico had the highest number of people fully vaccinated at 486,883 and the least number of people fully vaccinated was Utah at 365,762. Experts estimate that it will take somewhere around 70% of the population to achieve heard immunity but some experts says it would take up to 90%. With around 16% of the population fully vaccinated against COVID-19 as of March 31, and vaccination being an essential component for full reopening of the economy, WalletHub today released its report on the Safest States During COVID-19. Continue reading on Patch Farmington H
Read more